Author: BlueMed

CHRONIC KIDNEY DISEASE and blocked arteries

Is CHRONIC KIDNEY DISEASE in any way related to blocked arteries? Unfortunately, yes. 24% of Chronic Kidney Disease (CKD) patients also have Peripheral Arterial Disease (PAD). This number should not surprise you, considering CKD is an independent risk factor for the development of PAD, along with other cardiovascular risk factors (smoking, hypertension, diabetes, and overweight). On the other […]

Read More

The Effects of Age, Weight and Family History on Ankle-Brachial Index

Preventive screening fod PAD on the basis of ABI measurement is recommended for individuals who are older, over or underweight and have family history of PAD. There are many risk factors for Peripheral Arterial Disease (PAD) and some are non-modifiable and some are modifiable by a patient. And just as with any other disease, PAD […]

Read More

Vaccinium corymbosum: Overall improvement of eye health

Biloma is a new product with Blueberry extract, scientifically known as Vaccinium corymbosum. The oral intake of Biloma ensures immediate activation of all the beneficial properties of blueberry. Vaccinium corymbosum is rich in antioxidant vitamins A, C, E and B-carotene, potassium, magnesium, phosphorus, inorganic acids, minerals, pectin and fiber. In addition, the strong antioxidant activity […]

Read More

Biloma 316 mg: Health for the skin, multiple benefits

Biloma is a new product with blueberry extract, scientifically known as Vaccinium corymbosum. The blueberry is rich in antioxidant vitamins A, C, E and B-carotene, sugars, magnesium potassium, phosphorus, mineral acids, minerals, pectin and fiber. The oral intake of Biloma ensures immediate activation of its beneficial properties. Contributing to the fight against aging-related diseases. Its […]

Read More

STUDY OF EFFICACY AND SAFETY OF DIART® IN THE TREATMENT OF PATIENTS WITH KNEE OSTEOARTHRITIS OF THE II-III GRADE

OSTEOLOGY ISSUES. ACADEMIC AND PRACTICAL JOURNAL. VOLUME 15, NO. 2, 2012 Povorozniuk V.V.* Orlov E.V., Bistrytskaya M.A., Dzerovych N.I., Kozytskaya S.V. Povorozniuk V.V- prof., PhD, MD, President of the Ukrainian Association of osteoporosis and Ukrainian Association of menopause, andropause and diseases of the musculoskeletal system, board member of the International Association of Osteoporosis (IOF), Deputy […]

Read More

Help beat Economy Class Syndrome by wearing JET LEGS® Travel Socks!

Economy Class Syndrome can occur during long-haul flights, and in the worst case can lead to death. The causes of Economy Class Syndrome are as follows: Long periods of sitting with the knees bent = a reduction in the speed of bloodflow. Overeating = the stomach and intestines press against the blood vessels in the groin […]

Read More

Economy class syndrome: what is it and who are the individuals at risk?

Rev Bras Hematol Hemoter. 2017 Oct – Dec;39(4):349-353. doi: 10.1016/j.bjhh.2017.05.001. Epub 2017 May 26. Dusse LMS(1), Silva MVF(2), Freitas LG(2), Marcolino MS(2), Carvalho MDG(2). 1 Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil. Electronic address: lucidusse@gmail.com. 2 Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil. Abstract The term “Economy Class Syndrome” […]

Read More

Biloma 316 mg: Glycemic stability

Biloma 316 mg is a new product with blueberry extract (Vaccinium corymbosum), ideal for people with metabolic syndrome. Blueberry has been used over the centuries to deal with a variety of diseases in the form of sputum. It was known in antiquity as “myrtinitis wine” and “myrrhinous oil” and its beneficial properties were associated with […]

Read More

DIART INSTRUCTIONS FOR USE

Injectable Medical Device – based on Hyaluronic acid in syringe QUALITATIVE AND QUANTITATIVE COMPOSITION. Active substance: sodium hyaluronate. Excipients: succinic acid, sodium succinate, sodium chloride and water for injection. CLASSIFICATION OF THE PRODUCT Medical device – sterilized and pyrogen-free – Class III. PACKAGE 1ml pre-filled disposable syringe which contains 1.1 % (11mg) of hyaluronic acid. […]

Read More

DIART IN THE PATHOGENETIC TREATMENT OF OSTEOARTHRITIS

A. Burianov*, T. M. Omelchenko, U. L.Sobolevsky Bogomolets National Medical University, Kiev UCJ, Volume – № 3 (26) – 2012 pp. 31-38 Summary. Experimental study on 32 animals allowed to demonstrate and evaluate the severity of the antioxidant effect of a combination of hyaluronate and succinate compared with monotherapies hyaluronate. Clinical efficacy of a combination […]

Read More

PREVENTION AND TREATMENT OF POST-TRAUMATIC OSTEOARTHRITIS OF PATIENTS WITH INTRA-ARTICULAR OSTEOCHONDRAL FRACTURES

Original studies Volume 13, No.4 • 2012 UDC: 616.728.3-001 +617.583 Buryanov O.A., Omelchenko T.M., Sobolevskyi Y.L., Skopenko Y.O. Bohomolets National Medical University, Kyiv, Ukraine Introduction. Juxta- and intra-articular fractures of bones belong to a spread type of lesions, suffered by people of different age groups. Their occurrence, according to literature data, reaches 25-40% [1, 10, […]

Read More